Europe pharmacovigilance and drug safety software market was valued at $61.1 million in 2021 and will grow by 7.4% annually over 2021-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions.
Highlighted with 33 tables and 60 figures, this 119-page report Europe Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Europe pharmacovigilance and drug safety software market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe pharmacovigilance and drug safety software market in every aspect of the classification from perspectives of Functionality, Clinical Phase, Method, Delivery Mode, Indication, End User, and Country.

Based on Functionality, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software
Fully Integrated Software

Based on Clinical Phase, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Pre-clinical
Phase I
Phase II
Phase III
Phase IV

By Method, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining

By Delivery Mode, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
On-premise Delivery
On-demand Delivery

By Indication, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Oncology
Respiratory Disorders
Cardiology
Neurology
Immunology
Pain Management
Other Indications

By End Users, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Business Process Outsourcing Firms (BPOs)
Other End Users

Geographically, the following national/local markets are fully investigated:
Germany
UK
France
Spain
Italy
Netherlands
Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Functionality, Delivery Mode and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Ab Cube
Accenture PLC
ArisEurope LLC
Cognizant Technology Solutions Corporation
Ennov Solutions Inc.
Extedo GmbH
Honeywell International Inc. (Sparta Systems Inc.)
IQVIA Inc.
Max Application
Oracle Corporation
Sarjen Systems Pvt. Ltd.
United BioSource LLC
Veeva Systems Inc.
Wipro Limited
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)